ClinicalTrials.gg
Drug

Itepekimab clinical trials

Also written REGN3500 and SAR440340.

studies test it
17
open now
0
in phase 3
7
first study started
2016

How each study uses itepekimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Itepekimab (SAR440340)
7
Itepekimab SAR440340
3
Itepekimab
1

Development codes

REGN3500
17
SAR440340
2

Studies by the year they started

17 studies that test it; most in 2018 (4)

Studies that test itepekimab, by start year
YearStudies
20161
20172
20184
20201
20211
20221
20243
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
7
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 0

Sanofi (12) · Regeneron Pharmaceuticals (5)

Often tested with

Tested in the same studies.

Dupilumab (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test itepekimab, phase 3 first.

Studies

Open first, then newest update. How each study uses itepekimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call itepekimab · ClinicalTrials.gg INT001738

  • MeSH (NLM) C000720033itepekimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) WV9KZ9PS1AITEPEKIMABConfirmed FDA, NLM
  • NCI Thesaurus C174938ItepekimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.